Epoetin treatment improves red blood cell and plasma antioxidant capacity in hemodialysis patients.
The efficiency of human recombinant epoetin in alleviating anemia in hemodialyzed patients has been well documented. However, the effects of rhEPO therapy in correction of antioxidant capacity are not completely explained. In this study we examined both extracellular (plasma) and intracellular (red blood cells) antioxidant potential in hemodialyzed patients before and after three and six months of epoetin treatment by evaluating markers of oxidative stress (malondialdehyde) and antioxidant capacity (thiol groups, superoxide dismutase, and glutathione peroxidase). Six months of treatment with epoetin was followed by significant increases in thiol groups, superoxide dismutase and glutathione peroxidase activities in both plasma and red blood cells of hemodialyzed patients. Hence, during accelerated erythropoiesis, an increase in the number of young hematopoietic cells may replenish erythrocyte superoxide dismutase and glutathione peroxidase activity. However, the consequences of an imbalance between enzymatic antioxidant system (higher superoxide dismutase and lower glutathione peroxidase activity) that exists in these patients are the very high red blood cell and plasma malondialdehyde levels. These results suggest that, in spite of epoetin treatment and improvement in red blood cells and plasma antioxidant capacity, the production of reactive oxygen species overwhelms the intracellular and extracellular antioxidant capacity.
Mimic-Oka
Jasmina
J
Institute of Biochemistry, Faculty of Medicine, Clinical Center of Serbia, Belgrade, Yugoslavia. okasn@ptt.yu
Simic
Tatjana
T
Djukanovic
Ljubica
L
D000328:Adult; D000975:Antioxidants / Q000032:analysis*; D000068817:Epoetin Alfa; D004912:Erythrocytes / Q000378:metabolism; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005979:Glutathione Peroxidase / Q000097:blood; D006801:Humans; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D018384:Oxidative Stress / Q000187:drug effects; D011994:Recombinant Proteins; D006435:Renal Dialysis; D013438:Sulfhydryl Compounds / Q000097:blood; D013482:Superoxide Dismutase / Q000097:blood
D000975:Antioxidants; D011994:Recombinant Proteins; D013438:Sulfhydryl Compounds; D004921:Erythropoietin; D008315:Malondialdehyde; D000068817:Epoetin Alfa; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase